within Pharmacolibrary.Drugs.ATC.R;

model R06AX02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.34,
    Cl             = 0.02666666666666667,
    adminDuration  = 600,
    adminMass      = 4 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.02,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0038333333333333336,
    Tlag           = 10.200000000000001
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>R06AX02</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Cyproheptadine is a first-generation antihistamine with anticholinergic, antiserotonergic, and sedative properties. It is primarily used for the symptomatic relief of allergic conditions such as rhinitis, urticaria, and conjunctivitis. It has also been used for appetite stimulation, migraine prophylaxis, and treatment of serotonin syndrome. Cyproheptadine is an approved drug and is available in many countries.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters for healthy adult volunteers after a single oral dose.</p><h4>References</h4><ol><li><p>Gunja, N, et al., &amp; Graudins, A (2004). A comparison of the pharmacokinetics of oral and sublingual cyproheptadine. <i>Journal of toxicology. Clinical toxicology</i> 42(1) 79–83. DOI:<a href=&quot;https://doi.org/10.1081/clt-120028749&quot;>10.1081/clt-120028749</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/15083941/&quot;>https://pubmed.ncbi.nlm.nih.gov/15083941</a></p></li><li><p>Harada, T, et al., &amp; Shimizu, T (2017). Metoclopramide-induced Serotonin Syndrome. <i>Internal medicine (Tokyo, Japan)</i> 56(6) 737–739. DOI:<a href=&quot;https://doi.org/10.2169/internalmedicine.56.7727&quot;>10.2169/internalmedicine.56.7727</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/28321081/&quot;>https://pubmed.ncbi.nlm.nih.gov/28321081</a></p></li><li><p>McClellan, K, &amp; Jarvis, B (2001). Desloratadine. <i>Drugs</i> 61(6) 789–797. DOI:<a href=&quot;https://doi.org/10.2165/00003495-200161060-00007&quot;>10.2165/00003495-200161060-00007</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/11398910/&quot;>https://pubmed.ncbi.nlm.nih.gov/11398910</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end R06AX02;
